Stratified medicine has the potential to revolutionize medical care by utilizing an improved understanding of genetics and molecular biology. As a result, this will enable improved diagnostic tests, more precise diagnoses, greater predictability of disease course, and improved patient safety by selecting not only the right drug for a patient but also the appropriate dosage to reduce adverse effects.
ExL’s 2nd Stratified Medicine Conference will bring together the industry’s leading stratified and personalized medicine experts to provide you with unique take-home examples, case studies and multiple innovative strategies to implement stratified medicine initiatives within your own organizations.
By attending this conference, you will hear industry-specific case studies and examples including:
Benefit from industry participation from Pfizer, Merck, MedImmune, Johnson & Johnson, Novartis, Selventa, EMD Serono, Daiichi Sankyo, MIT, and many more personalized and stratified medicine innovators and experts.
Attend January’s Stratified Medicine Conference and join the industry’s leading stratified and personalized medicine experts to provide you with unique take-home examples, case studies and multiple innovative strategies to implement stratified medicine initiatives within your own organizations.
This is a MUST ATTEND event for professionals involved in stratified medicine, biomarkers, clinical development and personalized medicine. Participants will benefit from unique take-home examples, case studies and multiple clinical development strategies to assist in initiating and implementing a stratified medicines program, while shortening clinical phases, reducing costs, increasing approval rate, and time-to-market on your future drug products.
“Great presentations, clear discussions and good Q&A!”
– Director, Takeda
“Excellent discussions on challenges with biomarkers in drug development”
– Sr. Scientist, BD Diagnostics
“Great discussions, good content”
– Sajit Brar, FDA
CSOs, Vice Presidents, Heads, Directors, Scientists and Project Leaders of: